The combination of selected cytokines (sIL2—increased by antipsychotics, and IL-1β and IFN-γ—decreased by antipsychotics) could be used as marker of the treatment response, since antipsychotic treatment corrected the inflammation in schizophrenia [60]. The gene discussed is IL1B; the disease is schizophrenia.